We compared cardiovascular disease outcomes according to the presence of peripheral
arterial disease (PAD) at baseline in a post hoc analysis from the PROactive study. Of the …

Background Peripheral arterial disease (PAD) is known to be associated with high
cardiovascular risk, but the individual impact of PAD presentations on risk of macrovascular …

Peripheral arterial disease (PAD) is a chronic, lifestyle-limiting disease and is an
independent predictor of cardiovascular and cerebrovascular ischemic events. Despite the …

OBJECTIVE Peripheral arterial disease (PAD) is a common manifestation of atherosclerosis
in type 2 diabetes, but the relationship between other vascular diseases and PAD has been …

Background: Diabetes confers an increased risk for atherosclerotic cardiovascular disease,
but less is known about the independent risk diabetes confers on major cardiovascular and …

Background Diabetes confers an increased risk for atherosclerotic cardiovascular disease,
but less is known about the independent risk diabetes confers on major cardiovascular and …

The increased risk of atherothrombotic events present in all patients with peripheral arterial
disease (PAD) is amplified with concomitant diabetes. Moreover, diabetes is associated with …

Background Pre-diabetes and untreated diabetes are common in patients with peripheral
artery disease however their impact on outcome has not been evaluated. We examined the …

There are two points of view for the interplay of peripheral arterial disease (PAD) with
diabetes: the higher prevalence of PAD that is presented in diabetes than in the general …

OBJECTIVE—The PROspective pioglitAzone Clinical Trial In macroVascular Events
(PROactive) assesses the effect of pioglitazone, a peroxisome proliferator-activated receptor …